Literature DB >> 18426922

Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner.

Subba Rao Nallagatla1, Philip C Bevilacqua.   

Abstract

The human interferon-induced protein kinase PKR is a key component of innate immunity, a process in which it senses pathogenic RNA. PKR consists of an N-terminal dsRNA-binding domain (dsRBD) and a C-terminal kinase domain. Upon binding long (>33 base pairs) stretches of pathogenic dsRNA, PKR undergoes autophosphorylation, which activates it to phosphorylate eIF2alpha, leading to inhibition of translation initiation. Many cellular and viral transcripts contain nucleoside modifications, and these could affect PKR activation. For example, a 5'-triphosphate confers the ability of relatively unstructured transcripts to activate PKR. Effects of internal RNA modifications on PKR activation have not been reported. Herein, PKR activation by ssRNA and dsRNA containing internal nucleobase, sugar, and phosphodiester modifications is analyzed. We find that for 5'-triphosphate-containing ssRNA, most base and sugar modifications abrogate activation, although 2'-fluoro-modified ssRNA does not, indicative of a critical role for hydrogen bonding at the ribose sugar. In the case of dsRNA, a more limited set of nucleoside modifications affect PKR activation. Watson-Crick base-pairing is required for activation, and some minor groove modifications abrogate activation while major groove modifications have little effect. Surprisingly, GU wobble pairs also largely abrogate dsRNA-mediated activation when present at modest levels. Modifications to dsRNA that abrogate activation have no significant effect on dsRBD binding, allowing such RNAs to act as inhibitors and suggesting a nonequivalence of binding ability and activation. Overall, the findings indicate that nucleoside modifications and wobble pairing may serve to discriminate self-RNA and pathogenic RNA in innate immunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18426922      PMCID: PMC2390794          DOI: 10.1261/rna.1007408

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  44 in total

Review 1.  On the wobble GoU and related pairs.

Authors:  B Masquida; E Westhof
Journal:  RNA       Date:  2000-01       Impact factor: 4.942

Review 2.  siRNA and isRNA: two edges of one sword.

Authors:  Martin Schlee; Veit Hornung; Gunther Hartmann
Journal:  Mol Ther       Date:  2006-07-31       Impact factor: 11.454

3.  5'-Triphosphate RNA is the ligand for RIG-I.

Authors:  Veit Hornung; Jana Ellegast; Sarah Kim; Krzysztof Brzózka; Andreas Jung; Hiroki Kato; Hendrik Poeck; Shizuo Akira; Karl-Klaus Conzelmann; Martin Schlee; Stefan Endres; Gunther Hartmann
Journal:  Science       Date:  2006-10-12       Impact factor: 47.728

Review 4.  RNAi therapeutics: principles, prospects and challenges.

Authors:  Lars Aagaard; John J Rossi
Journal:  Adv Drug Deliv Rev       Date:  2007-03-16       Impact factor: 15.470

5.  Effect of base modifications on structure, thermodynamic stability, and gene silencing activity of short interfering RNA.

Authors:  Katarzyna Sipa; Elzbieta Sochacka; Julia Kazmierczak-Baranska; Maria Maszewska; Magdalena Janicka; Genowefa Nowak; Barbara Nawrot
Journal:  RNA       Date:  2007-06-21       Impact factor: 4.942

6.  RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates.

Authors:  Andreas Pichlmair; Oliver Schulz; Choon Ping Tan; Tanja I Näslund; Peter Liljeström; Friedemann Weber; Caetano Reis e Sousa
Journal:  Science       Date:  2006-10-12       Impact factor: 47.728

Review 7.  The dsRNA protein kinase PKR: virus and cell control.

Authors:  M A García; E F Meurs; M Esteban
Journal:  Biochimie       Date:  2007-03-12       Impact factor: 4.079

8.  Suppression of immunostimulatory siRNA-driven innate immune activation by 2'-modified RNAs.

Authors:  Mouldy Sioud; Gro Furset; Lina Cekaite
Journal:  Biochem Biophys Res Commun       Date:  2007-07-16       Impact factor: 3.575

9.  Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.

Authors:  Tao Lan; Ekambar R Kandimalla; Dong Yu; Lakshmi Bhagat; Yukui Li; Daqing Wang; Fugang Zhu; Jimmy X Tang; Mallikarjuna R Putta; YanPing Cong; Anthony F Trombino; Tim Sullivan; Sudhir Agrawal
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-14       Impact factor: 11.205

Review 10.  Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action.

Authors:  M A García; J Gil; I Ventoso; S Guerra; E Domingo; C Rivas; M Esteban
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

View more
  68 in total

1.  Minor-groove-modulating adenosine replacements control protein binding and RNAi activity in siRNAs.

Authors:  Hayden Peacock; Erik Fostvedt; Peter A Beal
Journal:  ACS Chem Biol       Date:  2010-10-07       Impact factor: 5.100

2.  2'Fluoro Modification Differentially Modulates the Ability of RNAs to Activate Pattern Recognition Receptors.

Authors:  Youngju Lee; Johannes H Urban; Li Xu; Bruce A Sullenger; Jaewoo Lee
Journal:  Nucleic Acid Ther       Date:  2016-01-20       Impact factor: 5.486

3.  Design, Assembly, Production, and Transfection of Synthetic Modified mRNA.

Authors:  Sanders Oh; John A Kessler
Journal:  Methods       Date:  2017-11-07       Impact factor: 3.608

4.  RNA helical imperfections regulate activation of the protein kinase PKR: effects of bulge position, size, and geometry.

Authors:  Laurie A Heinicke; Subba Rao Nallagatla; Chelsea M Hull; Philip C Bevilacqua
Journal:  RNA       Date:  2011-04-01       Impact factor: 4.942

Review 5.  mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.

Authors:  Giulietta Maruggi; Cuiling Zhang; Junwei Li; Jeffrey B Ulmer; Dong Yu
Journal:  Mol Ther       Date:  2019-02-07       Impact factor: 11.454

6.  Specificity of the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR for double-stranded RNA: insights from thermodynamics and small-angle X-ray scattering.

Authors:  Sunita Patel; Joshua M Blose; Joshua E Sokoloski; Lois Pollack; Philip C Bevilacqua
Journal:  Biochemistry       Date:  2012-11-09       Impact factor: 3.162

7.  Promiscuous 8-alkoxyadenosines in the guide strand of an siRNA: modulation of silencing efficacy and off-pathway protein binding.

Authors:  Uday Ghanty; Erik Fostvedt; Rachel Valenzuela; Peter A Beal; Cynthia J Burrows
Journal:  J Am Chem Soc       Date:  2012-10-11       Impact factor: 15.419

8.  Transfection of pseudouridine-modified mRNA encoding CPD-photolyase leads to repair of DNA damage in human keratinocytes: a new approach with future therapeutic potential.

Authors:  Gábor Boros; Edit Miko; Hiromi Muramatsu; Drew Weissman; Eszter Emri; Dávid Rózsa; Georgina Nagy; Attila Juhász; István Juhász; Gijsbertus van der Horst; Irén Horkay; Éva Remenyik; Katalin Karikó; Gabriella Emri
Journal:  J Photochem Photobiol B       Date:  2013-10-11       Impact factor: 6.252

9.  RNA dimerization promotes PKR dimerization and activation.

Authors:  Laurie A Heinicke; C Jason Wong; Jeffrey Lary; Subba Rao Nallagatla; Amy Diegelman-Parente; Xiaofeng Zheng; James L Cole; Philip C Bevilacqua
Journal:  J Mol Biol       Date:  2009-05-13       Impact factor: 5.469

10.  The autoinhibitory CARD2-Hel2i Interface of RIG-I governs RNA selection.

Authors:  Anand Ramanathan; Swapnil C Devarkar; Fuguo Jiang; Matthew T Miller; Abdul G Khan; Joseph Marcotrigiano; Smita S Patel
Journal:  Nucleic Acids Res       Date:  2015-11-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.